Nikolaus Marx (@UniklinikAachen) at #EASD2025 in Vienna: SOUL: Design, primary findings & CV outcomes by SGLT2i use Wed, 17 Sept 2025 |08:30-09:30 CEST Vienna Hall Plus expert insights from other leading voices easd.org/annual-meeting #diabetes
Who should consider semaglutide with glycine The glycine formulation may be particularly beneficial for specific patient populations
[2] The physiological changes that accompany weight loss and alterations in fluid balance, electrolyte levels, and dietary intake during Wegovy therapy may indirectly contribute to muscle cramping in some individuals
How We Got Here: A Short Field History Understanding why one of these peptides has robust human data and the other does not requires a little history, because the two molecules were developed to answer different questions in different eras
Do not use the medication
On the highest maintenance dose (15mg), Mounjaro was found to help people lose up to 22.5% of their starting weight after taking the dose for 72 weeks